Novo Nordisk’s diabetes drug Victoza has been pressing its cardiovascular advantage since last year. Now, its newest TV campaign doubles down on its approved trifecta of preventative indications for ...
In a year when GLP-1 drugs were a best-selling, buzzy phenomenon, Novo Nordisk’s ad spend for Ozempic in streaming TV has been paying off. The brand’s ads were 57% more effective in driving consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results